Page 11 - 2022-32-中国全科医学

·3976· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

TSP-1/TGFβ1 axis［J］. Clin Cancer Res，2018，24（23）： derived growth factor production by B16 melanoma cells leads to
6078-6097. DOI：10.1158/1078-0432.CCR-18-0693. increased pericyte abundance in tumors and an associated increase
［10］HAINSWORTH J D，SPIGEL D R，SOSMAN J A，et al. Treatment in tumor growth rate［J］. Cancer Res，2004，64（8）：2725-
of advanced renal cell carcinoma with the combination bevacizumab/ 2733. DOI：10.1158/0008-5472.can-03-1489.
erlotinib/imatinib：a phase Ⅰ / Ⅱ trial［J］. Clin Genitourin Cancer， ［25］YONENAGA Y，MORI A，ONODERA H，et al. Absence of
2007，5（7）：427-432. DOI：10.3816/CGC.2007.n.030. smooth muscle actin-positive pericyte coverage of tumor vessels
［11］HANAHAN D，WEINBERG R A. Hallmarks of cancer：the next correlates with hematogenous metastasis and prognosis of colorectal
generation［J］. Cell，2011，144（5）：646-674. DOI： cancer patients［J］. Oncology，2005，69（2）：159-166.
10.1016/j.cell.2011.02.013. ［26］ZHANG X N，YANG K D，CHEN C，et al. Pericytes augment
［12］PAIVA A E，LOUSADO L，GUERRA D A P，et al. Pericytes in glioblastoma cell resistance to temozolomide through CCL5-CCR5
the premetastatic niche［J］. Cancer Res，2018，78（11）： paracrine signaling［J］. Cell Res，2021，31（10）：1072-
2779-2786. DOI：10.1158/0008-5472.CAN-17-3883. 1087. DOI：10.1038/s41422-021-00528-3.
［13］WONG P P，DEMIRCIOGLU F，GHAZALY E，et al. Dual-action ［27］WONG P P，MUÑOZ-FÉLIXJ M，HIJAZI M，et al. Cancer
combination therapy enhances angiogenesis while reducing tumor burden is controlled by mural cell-β3-integrin regulated crosstalk
growth and spread［J］. Cancer Cell，2015，27（1）：123-137. with tumor cells［J］. Cell，2020，181（6）：1346-1363. e21.
DOI：10.1016/j.ccell.2014.10.015. DOI：10.1016/j.cell.2020.02.003.
［28］LECHERTIER T，REYNOLDS L E，KIM H，et al. Pericyte
［14］RIBATTI D，NICO B，CRIVELLATO E. The role of pericytes in
FAK negatively regulates Gas6/Axl signalling to suppress tumour
angiogenesis［J］. Int J Dev Biol，2011，55（3）：261-268.
angiogenesis and tumour growth［J］. Nat Commun，2020，11（1）：
DOI：10.1387/ijdb.103167dr.
2810. DOI：10.1038/s41467-020-16618-6.
［15］ARMULIK A，GENOVÉ G，BETSHOLTZ C. Pericytes：
［29］NAVARRO R，COMPTE M，ÁLVAREZ-VALLINA L，
developmental，physiological，and pathological perspectives，
et al. Immune regulation by pericytes：modulating innate and
problems，and promises［J］. Dev Cell，2011，21（2）：193-
adaptive immunity［J］. Front Immunol，2016，7：480. DOI：
215. DOI：10.1016/j.devcel.2011.07.001.
10.3389/fimmu.2016.00480.
［16］NWADOZI E，RUDNICKI M，HAAS T L. Metabolic coordination
［30］YANG Y，ANDERSSON P，HOSAKA K，et al. The PDGF-BB-
of pericyte phenotypes：therapeutic implications［J］. Front Cell
SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes
Dev Biol，2020，8：77. DOI：10.3389/fcell.2020.00077.
metastasis through tumour-associated macrophages［J］. Nat
［17］MATSUDA M，SEKI E. Hepatic stellate cell-macrophage crosstalk
Commun，2016，7：11385. DOI：10.1038/ncomms11385.
in liver fibrosis and carcinogenesis［J］. Semin Liver Dis，2020，
［31］QIAN B Z，POLLARD J W. Macrophage diversity enhances tumor
40（3）：307-320. DOI：10.1055/s-0040-1708876.
progression and metastasis［J］. Cell，2010，141（1）：39-51.
［18］KALLURI R. The biology and function of fibroblasts in
DOI：10.1016/j.cell.2010.03.014.
cancer［J］. Nat Rev Cancer，2016，16（9）：582-598. DOI：
［32］ZHU C，CHRIFI I，MUSTAFA D，et al. CECR1-mediated
10.1038/nrc.2016.73.
cross talk between macrophages and vascular mural cells promotes
［19］HOSAKA K，YANG Y，SEKI T，et al. Pericyte-fibroblast
neovascularization in malignant glioma［J］. Oncogene，2017，36
transition promotes tumor growth and metastasis［J］. Proc
（38）：5356-5368. DOI：10.1038/onc.2017.145.
Natl Acad Sci USA，2016，113（38）：E5618-5627. DOI：
［33］HONG J，TOBIN N P，RUNDQVIST H，et al. Role of tumor
10.1073/pnas.1608384113.
pericytes in the recruitment of myeloid-derived suppressor
［20］GUO P，HU B，GU W，et al. Platelet-derived growth factor-B
cells［J］. J Natl Cancer Inst，2015，107（10）：djv209. DOI：
enhances glioma angiogenesis by stimulating vascular endothelial
10.1093/jnci/djv209.
growth factor expression in tumor endothelia and by promoting ［34］HAMZAH J，JUGOLD M，KIESSLING F，et al. Vascular
pericyte recruitment［J］. Am J Pathol，2003，162（4）：1083- normalization in Rgs5-deficient tumours promotes immune
1093. DOI：10.1016/S0002-9440（10）63905-3. destruction［J］. Nature，2008，453（7193）：410-414. DOI：
［21］ARMULIK A，ABRAMSSON A，BETSHOLTZ C. Endothelial/ 10.1038/nature06868.
pericyte interactions［J］. Circ Res，2005，97（6）：512-523. ［35］TIAN L，GOLDSTEIN A，WANG H，et al. Mutual regulation
［22］SONG N，HUANG Y，SHI H，et al. Overexpression of platelet- of tumour vessel normalization and immunostimulatory
derived growth factor-BB increases tumor pericyte content via reprogramming［J］. Nature，2017，544（7649）：250-254.
stromal-derived factor-1alpha/CXCR4 axis［J］. Cancer Res， DOI：10.1038/nature21724.
2009，69（15）：6057-6064. DOI：10.1158/0008-5472.CAN- ［36］TAVERNARI D，BATTISTELLO E，DHEILLY E，et al.
08-2007. Nongenetic evolution drives lung adenocarcinoma spatial
［23］MENG M B，ZAORSKY N G，DENG L，et al. Pericytes：a heterogeneity and progression［J］. Cancer Discov，2021，11（6）：
double-edged sword in cancer therapy［J］. Future Oncol，2015， 1490-1507. DOI：10.1158/2159-8290.CD-20-1274.
11（1）：169-179. DOI：10.2217/fon.14.123. ［37］PÀEZ-RIBES M，ALLEN E，HUDOCK J，et al. Antiangiogenic
［24］FURUHASHI M，SJÖBLOM T，ABRAMSSON A，et al. Platelet- therapy elicits malignant progression of tumors to increased local